Charles S. Ryan

Insider Reports History

Entity
Individual
Location
C/O Applied Dna Sciences, Inc., 50 Health Sciences Drive, Stony Brook, NY
Signature
/s/ Brendan Hannah, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles S. Ryan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Quince Therapeutics, Inc. PRESIDENT Common Stock 122K $79.6K $0.65 Aug 20, 2024 Direct
Quince Therapeutics, Inc. PRESIDENT Employee Stock Option (right to buy) 145K Feb 1, 2024 Direct

Insider Reports Filed by Charles S. Ryan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QNCX Quince Therapeutics, Inc. Aug 20, 2024 1 $31.5K 4 Aug 22, 2024 PRESIDENT
QNCX Quince Therapeutics, Inc. Feb 1, 2024 1 $0 4 Feb 2, 2024 PRESIDENT
QNCX Quince Therapeutics, Inc. Sep 1, 2023 1 $0 4 Sep 6, 2023 President
QNCX Quince Therapeutics, Inc. Sep 1, 2023 0 $0 3 Sep 6, 2023 President